{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:30Z","timestamp":1746331650964,"version":"3.40.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Takayasu arteritis (TAK) is an autoimmune disease that causes chronic inflammation targeting the aortic wall. Since many patients are resistant to steroid treatment, multiple immunosuppressants or interleukin-6 (IL-6) suppression therapy have served as treatment alternatives. However, there are very few reports on the effectiveness of biologics against inflammatory cytokines upstream of IL-6.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a case of TAK in a 51-year-old female presenting with a myocardial infarction. She had persistent carotid wall thickening despite glucocorticoid (GC) therapy, and IL-6 suppression therapy was being proactively considered. While the GC was being tapered, widespread pustules appeared all over her body.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>TAK complicated with generalized pustular psoriasis (GPP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Aside from GC, the patient was treated with secukinumab (SEC), an anti-IL-17A monoclonal antibody.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Immediately after treatment with SEC, the pustules disappeared, and the thickening of the common carotid artery wall improved on ultrasound.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Since IL-17 is an important cytokine in the pathogenesis of TAK, anti-cytokine therapy targeting IL-17 may be effective for TAK.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040994","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:04:06Z","timestamp":1734725046000},"page":"e40994","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of secukinumab in Takayasu arteritis with myocardial infarction complicated with generalized pustular psoriasis: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6538-1881","authenticated-orcid":false,"given":"Tomoyuki","family":"Asano","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-3136","authenticated-orcid":false,"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-196X","authenticated-orcid":false,"given":"Masato","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sumichika","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4305-2048","authenticated-orcid":false,"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8110-8261","authenticated-orcid":false,"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-2573","authenticated-orcid":false,"given":"Toshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"},{"name":"Department of Rheumatology, St. Francis Hospital, Nagasaki, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu arteritis.","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis.","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","article-title":"Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).","volume":"77","author":"Nakaoka","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajhg.2013.05.024","article-title":"Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population.","volume":"93","author":"Terao","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/14397595.2020.1800560","article-title":"Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab.","volume":"31","author":"Gon","year":"2021","journal-title":"Mod Rheumatol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1066916","DOI":"10.3389\/fimmu.2022.1066916","article-title":"Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel vasculitis: a preliminary observational study.","volume":"13","author":"Abe","year":"2022","journal-title":"Front Immunol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis.","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1253\/circj.CJ-19-0773","article-title":"JCS 2017 guideline on management of vasculitis syndrome-digest version.","volume":"84","author":"Isobe","year":"2020","journal-title":"Circ J"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3899\/jrheum.121276","article-title":"Cutaneous manifestations and comorbidities in 60 cases of Takayasu arteritis.","volume":"40","author":"Rocha","year":"2013","journal-title":"J Rheumatol"},{"key":"R10-20250503","first-page":"61","article-title":"Takayasu\u2019s arteritis: associated inflammatory diseases.","volume":"38","author":"Esatoglu","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R11-20250503","first-page":"563","article-title":"Erythema nodosum: an evaluation of 100 cases.","volume":"25","author":"Mert","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1756-185X.13288","article-title":"Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease?","volume":"22","author":"Kermani","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1148\/radiol.13122195","article-title":"Takayasu arteritis: assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta.","volume":"270","author":"Kang","year":"2014","journal-title":"Radiology"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12872-019-1066-7","article-title":"Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.","volume":"19","author":"Yokokawa","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijcard.2017.02.086","article-title":"Incidence, prevalence, mortality and causes of death in Takayasu arteritis in Korea-a nationwide, population-based study.","volume":"235","author":"Park","year":"2017","journal-title":"Int J Cardiol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-019-04818-5","article-title":"Association between Takayasu arteritis and latent or active mycobacterium tuberculosis infection: a systematic review.","volume":"39","author":"Pedreira","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13075-017-1408-8","article-title":"A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.","volume":"19","author":"Nakajima","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/03009742.2015.1060521","article-title":"Ustekinumab as a therapeutic option for Takayasu arteritis: from genetic findings to clinical application.","volume":"45","author":"Terao","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/mrcr\/rxac090","article-title":"Successful treatment of a patient with Takayasu\u2019s arteritis complicated with Crohn\u2019s disease with ustekinumab: a case report.","volume":"7","author":"Suga","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system.","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","article-title":"The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation.","volume":"18","author":"Kikly","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome.","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of Interleukin-17 family members.","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"R24-20250503","first-page":"1102","article-title":"CYR61\/TGF-\u03b2 axis promotes adventitial fibrosis of Takayasu\u2019s arteritis in the IL-17 mediated inflammatory microenvironment.","volume":"38","author":"Ma","year":"2020","journal-title":"Clin Exp Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:28:49Z","timestamp":1746318529000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":24,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040994","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}